Feb. 23 at 1:06 AM
$ENZN STay away
Enzon Pharmaceuticals, Inc. (OTC: ENZN) is a biotech company that historically focused on developing treatments for cancer and rare diseases using proprietary PEGylation technology (modifying drugs with polyethylene glycol to improve delivery). However, it’s largely considered a shell company today, having sold off most assets (e.g., PEG-SN38 and other products) years ago. It’s now a micro-cap traded over-the-counter, with minimal operations beyond managing royalty streams and cash reserves.